BIND Therapeutics Inc Stock Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-10-31 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | - | 16-07-23 |
1st Jan change | Capi. | |
---|---|---|
-3.14% | 102B | |
+1.73% | 96.07B | |
-1.80% | 21.66B | |
-17.47% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.10% | 13.79B | |
-0.11% | 13.33B | |
+20.66% | 10.94B |